subperiosteal implants
Use of Subperiosteal Implants with Distal Filling Ports in the Correction of the Atrophic Alveolar Ridge
- 20 February 1991
- Posted by: anjaform
- Category: Clinical Studies and Case Reports
D.Lew, R. M. Hinkle, S. F. Collins
Full text link: https://pubmed.ncbi.nlm.nih.gov/2019776/
Use of Subperiosteal Implants with Distal Filling Ports in the Correction of the Atrophic Alveolar Ridge
1. Scientific Reference
- Study title: Use of subperiosteal implants with distal filling ports in the correction of the atrophic alveolar ridge
- Authors: D. Lew, R. M. Hinkle, S. F. Collins
- Scientific journal: Not specified in the information provided.
- Year of publication: Not specified in the information provided.
- PMID: 2019776
- DOI: 10.1016/S0901-5027(05)80688-5
2. Scientific Background
Management of a markedly atrophic alveolar ridge can present significant surgical challenges, particularly when severe mandibular resorption reduces the anatomical margin available for intervention. In this study, Lew and colleagues focused on a subperiosteal tissue-expansion device whose design was modified by relocating the filling port to the distal end of the prosthesis.
The clinical rationale for this modification arose from difficulties encountered with an earlier configuration. According to the authors, placement of the original centrally located filling port required a midline incision that was associated with wound dehiscence. Severe mandibular atrophy also raised concerns regarding injury to the inferior alveolar nerve during device insertion.
Rather than assessing implant rehabilitation as a whole, this report therefore addresses a specific technical question: whether changing the position of the filling port and adapting the surgical access could help overcome complications associated with the previous design.
3. Study Objective
The study aimed to report the clinical use of a subperiosteal tissue expander incorporating a filling port positioned at the distal end of the prosthesis.
Based on the available abstract, the principal purpose of this design modification was to avoid problems associated with the previous midline approach and centrally positioned filling port, while allowing an alternative insertion technique in patients with severe mandibular atrophy.
No additional predefined primary or secondary objectives are detailed in the information provided.
4. Methodology
The authors report clinical experience with the modified subperiosteal tissue expander in 10 patients over a two-year period. The exact methodological classification of the study is not stated in the abstract. Based solely on the information available, it can cautiously be regarded as a small descriptive clinical series.
The device incorporated a filling port attached to its distal end. This configuration allowed the authors to avoid the previous midline insertion approach and made bilateral incision or insertion possible.
Important methodological information is not provided. The abstract does not specify patient demographics, individual follow-up duration, detailed inclusion criteria, the number of devices placed, standardized outcome measures, or statistical methods. These omissions substantially limit a more detailed assessment of the study design.
5. Main Results
The principal observation concerns wound dehiscence. With the modified design, the authors report elimination of the dehiscence problem they had previously encountered when using a midline incision to place the original expander with its centrally positioned filling port.
A second finding relates to the inferior alveolar nerve in severely atrophic mandibles. The possibility of using a bilateral approach for insertion was reported to reduce the incidence of nerve injury.
The abstract does not provide numerical complication rates, statistical analyses, or a quantitative comparison between the original and modified configurations. It also does not describe other surgical complications, functional outcomes, prosthetic outcomes, or long-term results.
The available findings should therefore be interpreted primarily as clinical observations concerning surgical access, wound dehiscence, and inferior alveolar nerve injury rather than as evidence of overall treatment efficacy.
6. Clinical Analysis
The main clinical value of this report lies in the relationship it highlights between device design, surgical access, and procedure-related complications. Moving the filling port from a central to a distal position appears to have changed more than the physical configuration of the prosthesis: it allowed the surgical approach itself to be reconsidered.
In the authors’ experience, avoiding the previous midline approach addressed the dehiscence problem encountered with the earlier design. The option of bilateral insertion was also considered relevant in the severely atrophic mandible, where the inferior alveolar nerve represents an important anatomical consideration.
These observations illustrate how technical modifications to an implant-related device may influence surgical feasibility and complication patterns. However, their clinical significance should not be overstated. Only 10 patients are described, and the abstract provides no formal comparative group, statistical analysis, or quantitative complication data.
Consequently, the study does not establish the superiority of this technique over alternative approaches to the atrophic alveolar ridge. Nor does it provide sufficient evidence to formulate broader treatment recommendations. Its contribution is better understood as a focused clinical and technical observation regarding a modified subperiosteal device and its insertion strategy.
7. Clinical Applications
The findings are potentially relevant to the surgical management of patients with a markedly atrophic alveolar ridge, particularly in cases involving severe mandibular atrophy.
Within the specific setting described by the authors, distal positioning of the filling port allowed an alternative surgical approach intended to address two previously encountered problems: wound dehiscence associated with a midline incision and injury to the inferior alveolar nerve.
The information provided does not support extrapolation to other implant rehabilitation protocols, bone augmentation procedures, or different categories of implant-supported rehabilitation. Likewise, the abstract does not provide evidence allowing this technique to be compared with other methods for managing severe alveolar ridge atrophy.
Its clinical relevance should therefore remain confined to the specific technical circumstances documented in this report.
8. Level of Evidence, Limitations, and Transparency
The available information describes clinical experience in 10 patients and is consistent with a small descriptive clinical series, although the exact study design is not formally stated. Accordingly, the level of evidence should be considered limited.
The small patient population restricts the strength and generalizability of the findings. In addition, the abstract provides no detailed control group, statistical analysis, numerical complication rates, standardized outcome criteria, or patient-level follow-up data. These limitations prevent a robust assessment of the magnitude of the reported benefit.
No information regarding author conflicts of interest, financial relationships, or manufacturer affiliations is included in the material provided. It is therefore not possible to assess potential conflicts of interest from the available abstract alone.
9. Key Study Points
- Study type: Descriptive clinical experience; exact methodological classification not specified.
- Level of evidence: Limited/low based on the information available.
- Population: Patients treated in the context of an atrophic alveolar ridge; detailed characteristics not provided.
- Number of patients or implants: 10 patients; number of implants/devices not specified.
- Follow-up: Individual follow-up duration not specified; clinical experience reported over a two-year period.
- Primary outcome: Not formally defined; reported observations focused on dehiscence and inferior alveolar nerve injury.
- Main result: The modified design was reported to eliminate the previously encountered dehiscence problem and to reduce the incidence of inferior alveolar nerve injury.
- Scientific conclusion: Distal positioning of the filling port and modification of the insertion approach appeared favorable in the clinical experience reported.
- Main limitations: Small sample, limited methodological information, absence of detailed quantitative outcomes, and no formal comparative data in the abstract provided.
10. Scientific Impact
This publication is primarily relevant as a technical contribution to the management of the atrophic alveolar ridge using a subperiosteal device. Its scientific interest lies in showing how a targeted design modification may affect the surgical approach and, potentially, the complications associated with device placement.
The study draws attention to an important principle in oral and implant surgery: the geometry and accessibility of a device can influence not only its placement but also the surrounding soft tissues and anatomical structures. In this case, relocation of the filling port permitted a different insertion strategy that was associated with favorable observations regarding dehiscence and inferior alveolar nerve injury.
However, the available evidence remains exploratory. The report does not establish comparative effectiveness, quantify the magnitude of risk reduction, or provide long-term outcome data. Its contribution should therefore be viewed as a clinically relevant technical observation that would require more robust comparative evidence to support broader conclusions.
11. Editorial Conclusion
Lew, Hinkle, and Collins describe a technical modification of a subperiosteal tissue-expansion device intended for the management of an atrophic alveolar ridge. In their 10-patient experience, distal positioning of the filling port was associated with resolution of a previously encountered dehiscence problem, while bilateral insertion was reported to reduce inferior alveolar nerve injury in severely atrophic mandibles. Given the small sample and limited methodological detail, these findings remain preliminary and should be interpreted as a focused technical clinical observation rather than definitive evidence of therapeutic superiority.
